Cargando…

Protein-enriched meal replacements do not adversely affect liver, kidney or bone density: an outpatient randomized controlled trial

BACKGROUND: There is concern that recommending protein-enriched meal replacements as part of a weight management program could lead to changes in biomarkers of liver or renal function and reductions in bone density. This study was designed as a placebo-controlled clinical trial utilizing two isocalo...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhaoping, Treyzon, Leo, Chen, Steve, Yan, Eric, Thames, Gail, Carpenter, Catherine L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023677/
https://www.ncbi.nlm.nih.gov/pubmed/21194471
http://dx.doi.org/10.1186/1475-2891-9-72
_version_ 1782196676316889088
author Li, Zhaoping
Treyzon, Leo
Chen, Steve
Yan, Eric
Thames, Gail
Carpenter, Catherine L
author_facet Li, Zhaoping
Treyzon, Leo
Chen, Steve
Yan, Eric
Thames, Gail
Carpenter, Catherine L
author_sort Li, Zhaoping
collection PubMed
description BACKGROUND: There is concern that recommending protein-enriched meal replacements as part of a weight management program could lead to changes in biomarkers of liver or renal function and reductions in bone density. This study was designed as a placebo-controlled clinical trial utilizing two isocaloric meal plans utilizing either a high protein-enriched (HP) or a standard protein (SP) meal replacement in an outpatient weight loss program. SUBJECTS/METHODS: 100 obese men and women over 30 years of age with a body mass index (BMI) between 27 to 40 kg/m(2 )were randomized to one of two isocaloric weight loss meal plans 1). HP group: providing 2.2 g protein/kg of lean body mass (LBM)/day or 2). SP group: providing 1.1 g protein/kg LBM/day. Meal replacement (MR) was used twice daily (one meal, one snack) for 3 months and then once a day for 9 months. Body weight, lipid profiles, liver function, renal function and bone density were measured at baseline and 12 months. RESULTS: Seventy subjects completed the study. Both groups lost weight (HP -4.29 ± 5.90 kg vs. SP -4.66 ± 6.91 kg, p < 0.01) and there was no difference in weight loss observed between the groups at one year. There was no significant change noted in liver function [AST (HP -2.07 ± 10.32 U/L, p = 0.28; SP 0.27 ± 6.67 U/L, p = 0.820), ALT (HP -1.03 ± 10.08 U/L, p = 0.34; SP -2.6 ± 12.51 U/L, p = 0.24), bilirubin (HP 0.007 ± 0.33, U/L, p = 0.91; SP 0.07 ± 0.24 U/L, p = 0.120), alkaline phosphatase (HP 2.00 ± 9.07 U/L, p = 0.240; SP -2.12 ± 11.01 U/L, p = 0.280)], renal function [serum creatinine (HP 0.31 ± 1.89 mg/dL, p = 0.380; SP -0.05 ± 0.15 mg/dL, p = 0.060), urea nitrogen (HP 1.33 ± 4.68 mg/dL, p = 0.130; SP -0.24 ± 3.03 mg/dL, p = 0.650), 24 hour urine creatinine clearance (HP -0.02 ± 0.16 mL/min, p = 0.480; SP 1.18 ± 7.53 mL/min, p = 0.400), and calcium excretion (HP -0.41 ± 9.48 mg/24 hours, p = 0.830; SP -0.007 ± 6.76 mg/24 hours, p = 0.990)] or in bone mineral density by DEXA (HP 0.04 ± 0.19 g/cm(2), p = 0.210; SP -0.03 ± 0.17 g/cm(2), p = 0.320) in either group over one year. CONCLUSIONS: These studies demonstrate that protein-enriched meals replacements as compared to standard meal replacements recommended for weight management do not have adverse effects on routine measures of liver function, renal function or bone density at one year. Clinicaltrial.gov: NCT01030354.
format Text
id pubmed-3023677
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30236772011-01-20 Protein-enriched meal replacements do not adversely affect liver, kidney or bone density: an outpatient randomized controlled trial Li, Zhaoping Treyzon, Leo Chen, Steve Yan, Eric Thames, Gail Carpenter, Catherine L Nutr J Research BACKGROUND: There is concern that recommending protein-enriched meal replacements as part of a weight management program could lead to changes in biomarkers of liver or renal function and reductions in bone density. This study was designed as a placebo-controlled clinical trial utilizing two isocaloric meal plans utilizing either a high protein-enriched (HP) or a standard protein (SP) meal replacement in an outpatient weight loss program. SUBJECTS/METHODS: 100 obese men and women over 30 years of age with a body mass index (BMI) between 27 to 40 kg/m(2 )were randomized to one of two isocaloric weight loss meal plans 1). HP group: providing 2.2 g protein/kg of lean body mass (LBM)/day or 2). SP group: providing 1.1 g protein/kg LBM/day. Meal replacement (MR) was used twice daily (one meal, one snack) for 3 months and then once a day for 9 months. Body weight, lipid profiles, liver function, renal function and bone density were measured at baseline and 12 months. RESULTS: Seventy subjects completed the study. Both groups lost weight (HP -4.29 ± 5.90 kg vs. SP -4.66 ± 6.91 kg, p < 0.01) and there was no difference in weight loss observed between the groups at one year. There was no significant change noted in liver function [AST (HP -2.07 ± 10.32 U/L, p = 0.28; SP 0.27 ± 6.67 U/L, p = 0.820), ALT (HP -1.03 ± 10.08 U/L, p = 0.34; SP -2.6 ± 12.51 U/L, p = 0.24), bilirubin (HP 0.007 ± 0.33, U/L, p = 0.91; SP 0.07 ± 0.24 U/L, p = 0.120), alkaline phosphatase (HP 2.00 ± 9.07 U/L, p = 0.240; SP -2.12 ± 11.01 U/L, p = 0.280)], renal function [serum creatinine (HP 0.31 ± 1.89 mg/dL, p = 0.380; SP -0.05 ± 0.15 mg/dL, p = 0.060), urea nitrogen (HP 1.33 ± 4.68 mg/dL, p = 0.130; SP -0.24 ± 3.03 mg/dL, p = 0.650), 24 hour urine creatinine clearance (HP -0.02 ± 0.16 mL/min, p = 0.480; SP 1.18 ± 7.53 mL/min, p = 0.400), and calcium excretion (HP -0.41 ± 9.48 mg/24 hours, p = 0.830; SP -0.007 ± 6.76 mg/24 hours, p = 0.990)] or in bone mineral density by DEXA (HP 0.04 ± 0.19 g/cm(2), p = 0.210; SP -0.03 ± 0.17 g/cm(2), p = 0.320) in either group over one year. CONCLUSIONS: These studies demonstrate that protein-enriched meals replacements as compared to standard meal replacements recommended for weight management do not have adverse effects on routine measures of liver function, renal function or bone density at one year. Clinicaltrial.gov: NCT01030354. BioMed Central 2010-12-31 /pmc/articles/PMC3023677/ /pubmed/21194471 http://dx.doi.org/10.1186/1475-2891-9-72 Text en Copyright ©2010 Li et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Li, Zhaoping
Treyzon, Leo
Chen, Steve
Yan, Eric
Thames, Gail
Carpenter, Catherine L
Protein-enriched meal replacements do not adversely affect liver, kidney or bone density: an outpatient randomized controlled trial
title Protein-enriched meal replacements do not adversely affect liver, kidney or bone density: an outpatient randomized controlled trial
title_full Protein-enriched meal replacements do not adversely affect liver, kidney or bone density: an outpatient randomized controlled trial
title_fullStr Protein-enriched meal replacements do not adversely affect liver, kidney or bone density: an outpatient randomized controlled trial
title_full_unstemmed Protein-enriched meal replacements do not adversely affect liver, kidney or bone density: an outpatient randomized controlled trial
title_short Protein-enriched meal replacements do not adversely affect liver, kidney or bone density: an outpatient randomized controlled trial
title_sort protein-enriched meal replacements do not adversely affect liver, kidney or bone density: an outpatient randomized controlled trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023677/
https://www.ncbi.nlm.nih.gov/pubmed/21194471
http://dx.doi.org/10.1186/1475-2891-9-72
work_keys_str_mv AT lizhaoping proteinenrichedmealreplacementsdonotadverselyaffectliverkidneyorbonedensityanoutpatientrandomizedcontrolledtrial
AT treyzonleo proteinenrichedmealreplacementsdonotadverselyaffectliverkidneyorbonedensityanoutpatientrandomizedcontrolledtrial
AT chensteve proteinenrichedmealreplacementsdonotadverselyaffectliverkidneyorbonedensityanoutpatientrandomizedcontrolledtrial
AT yaneric proteinenrichedmealreplacementsdonotadverselyaffectliverkidneyorbonedensityanoutpatientrandomizedcontrolledtrial
AT thamesgail proteinenrichedmealreplacementsdonotadverselyaffectliverkidneyorbonedensityanoutpatientrandomizedcontrolledtrial
AT carpentercatherinel proteinenrichedmealreplacementsdonotadverselyaffectliverkidneyorbonedensityanoutpatientrandomizedcontrolledtrial